Piekos Brian
KalVista Pharmaceuticals, Inc. · Chief Financial Officer
Piekos Brian is listed in filings as Chief Financial Officer at KalVista Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to KalVista Pharmaceuticals, Inc. (KALV). The current snapshot covers public activity from Sep 11, 2024 to May 26, 2026. Reported amounts are shown as $39.9K to $27.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $38k1.9k shares | SellApr 17, 2026 | $20.22 | $26.79 | |
| $28k1.8k shares | SellFeb 23, 2026 | $15.57 | $26.79 | |
| $60k4.5k shares | SellNov 24, 2025 | $13.45 | $26.79 |